Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16051921rdf:typepubmed:Citationlld:pubmed
pubmed-article:16051921lifeskim:mentionsumls-concept:C0010823lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C0003451lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C0014597lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C0021853lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C0009368lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C1425473lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C1425474lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:16051921lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:16051921pubmed:issue5lld:pubmed
pubmed-article:16051921pubmed:dateCreated2005-10-17lld:pubmed
pubmed-article:16051921pubmed:abstractTextHuman cytomegalovirus virus (CMV) is a major cause of morbidity and mortality in immunocompromised individuals. Recently, a novel group of cytokines [interleukin (IL)-28A/B and IL-29, also termed interferon (IFN)-lambdas] has been described. Here, we demonstrate that intestinal epithelial cell (IEC) lines as well as murine and human colonic tissue express the IFN-lambda receptor subunits IL-28R and IL-10R2. IL-28A and IL-29 binding to their receptor complex activates ERK-1/2 and stress-activated protein kinase/c-Jun NH2-terminal kinase MAPKs and Akt, resulting in increased IL-8 protein expression. IFN-lambdas also induce phosphorylation of signal transducer and activator of transcription 1 and significantly increase mRNA expression of suppressor of cytokine signaling 3 and the antiviral proteins myxovirus resistance A and 2',5'-oligoadenylate synthetase. These signals result in an up to 83% reduction of cells positive for human CMV immediate-early protein after human CMV infection. In mice, IL-28A mRNA expression is upregulated after infection with murine CMV in vivo. Both IL-28A and IL-29 significantly decrease cell proliferation but have no effect on Fas-induced apoptosis. In conclusion, IECs express functional receptors for IFN-lambdas, which mediate antiviral and antiproliferative signals in IECs, suggesting a potential for therapeutic use in certain viral infections and as (antiproliferative) anticancer therapy.lld:pubmed
pubmed-article:16051921pubmed:languageenglld:pubmed
pubmed-article:16051921pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:citationSubsetIMlld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051921pubmed:statusMEDLINElld:pubmed
pubmed-article:16051921pubmed:monthNovlld:pubmed
pubmed-article:16051921pubmed:issn0193-1857lld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:AdlerBarbaraBlld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:BrandStephanSlld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:EichhorstSöre...lld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:GökeBurkhardBlld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:DieboldJoachi...lld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:DiepolderHelm...lld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:OtteJan-Miche...lld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:AuernhammerCh...lld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:ZitzmannKathr...lld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:DambacherJuli...lld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:BeigelFlorian...lld:pubmed
pubmed-article:16051921pubmed:authorpubmed-author:OlszakTorsten...lld:pubmed
pubmed-article:16051921pubmed:issnTypePrintlld:pubmed
pubmed-article:16051921pubmed:volume289lld:pubmed
pubmed-article:16051921pubmed:ownerNLMlld:pubmed
pubmed-article:16051921pubmed:authorsCompleteYlld:pubmed
pubmed-article:16051921pubmed:paginationG960-8lld:pubmed
pubmed-article:16051921pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:meshHeadingpubmed-meshheading:16051921...lld:pubmed
pubmed-article:16051921pubmed:year2005lld:pubmed
pubmed-article:16051921pubmed:articleTitleIL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression.lld:pubmed
pubmed-article:16051921pubmed:affiliationDepartment of Medicine II, University-Hospital Munich-Grosshadern, University of Munich, D-81377 Munich, Germany. stephan.brand@med.uni-muenchen.delld:pubmed
pubmed-article:16051921pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16051921pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:282616entrezgene:pubmedpubmed-article:16051921lld:entrezgene
entrez-gene:282618entrezgene:pubmedpubmed-article:16051921lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16051921lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16051921lld:entrezgene
lhgdn:association:11873lhgdn:found_inpubmed-article:16051921lld:lhgdn
lhgdn:association:11875lhgdn:found_inpubmed-article:16051921lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051921lld:pubmed